Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where CEMIPLIMAB was used for Prostate cancer.

Most Reported Side Effects for CEMIPLIMAB

Side Effect Reports % Deaths Hosp.
Fatigue 68 6.7% 8 34
Pyrexia 49 4.8% 9 41
Pneumonia 41 4.0% 3 34
Dyspnoea 40 3.9% 7 28
Pneumonitis 38 3.7% 15 25
Off label use 35 3.4% 11 19
Diarrhoea 34 3.3% 3 12
Rash 34 3.3% 1 13
Cytokine release syndrome 33 3.2% 5 30
Pain 33 3.2% 4 16
Asthenia 32 3.1% 5 21
Nausea 31 3.0% 1 12
Anaemia 30 2.9% 9 27
Disease progression 30 2.9% 11 11
Drug ineffective 30 2.9% 8 15

Other Indications for CEMIPLIMAB

Squamous cell carcinoma of skin (245) Squamous cell carcinoma (80) Product used for unknown indication (62) Non-small cell lung cancer (51) Neoplasm malignant (47) Non-small cell lung cancer stage iv (41) Basal cell carcinoma (38) Lung adenocarcinoma stage iv (37) Malignant melanoma (34) Metastatic squamous cell carcinoma (34)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

CEMIPLIMAB Full Profile All Prostate cancer Drugs CEMIPLIMAB Demographics CEMIPLIMAB Timeline